Forian Inc (FORA)

In the past six months, Forian Inc.'s stock price has been impacted by several events. Q3 2024 financial results announced in November 2024 showed a decline in revenue. The acquisition of Kyber Data Science in November 2024 aimed to enhance data analytics capabilities. A partnership with Databricks in December 2024 sought to expand access to advanced healthcare analytics. A Q4 2025 EPS miss was reported in April 2026. A going-private deal and tender offer were launched in April 2026, with a Wygod-led group reporting 70.5% control. An amendment to its annual report in April 2026 cited internal control weaknesses, contributing to restating 2023 financial statements.

Forian Inc. expects to experience seasonality in its results, but specific details on the nature or patterns of this demand seasonality are not provided.

Forian, Inc. is a healthtech company providing data science-driven information and analytics solutions, operating primarily in the Healthcare sector. It offers data management capabilities and analytics solutions to optimize operational, clinical, and financial performance. Forian serves industries including life sciences, pharmaceutical services, healthcare payer, provider, and financial services. Major solutions include data management and analytics, commercial real-world evidence, market access solutions, CHRONOS, Chartis, and Kyber Data Science.

Forian, Inc. operates across the United States, with a more significant presence on the East Coast compared to the West Coast. Its government-related business extends to 13 states. The company's principal executive offices are located in Newtown, Pennsylvania.

Forian has been actively working to establish its brand in the past year, aiming to build a reliable and scalable brand in the healthcare information space. However, internal control weaknesses and auditor changes, as revealed in an SEC filing in April 2026, could impact its reputation. Forian underperforms its industry peers in news mentions, suggesting a relatively low public visibility.

Forian Inc. has a concentrated ownership structure, with a consortium led by Max C. Wygod owning 70.5% of the company as of March 25, 2026. Major institutional owners and shareholders include Oracle Investment Management Inc., Staley Capital Advisers Inc., and Vanguard Group Inc. Institutional investors hold 19.25% of Forian's stock.